Day: June 7, 2020

China Defends Its Coronavirus Response

The Chinese government on Sunday strongly defended its handling of the coronavirus, pushing back at criticism that officials had suppressed early reports of the outbreak and contending instead that China had set a strong example for how to combat it.

A top Chinese official said at a news conference in Beijing that the government and state news media had provided early, timely and extensive information since the first cases appeared in Hubei Province late last year. In an apparent reference to the Trump administration’s numerous assertions that China is to blame for the subsequent pandemic, he complained bitterly about what he described as foreign lies and slanders.

“Those are completely unwarranted and unreasonable,” said the official, Xu Lin, who oversees the State Council Information Office. On Sunday the agency published a detailed report on China’s epidemic response.

Ma Xiaowei,

Read More

Two Huge Covid-19 Studies Are Retracted After Scientists Sound Alarms

The studies, published in renowned scientific journals, produced astounding results and altered the course of research into the coronavirus pandemic.

One undercut President Trump’s claim that certain antimalarial drugs cure Covid-19, the illness caused by the virus, concluding that the medications in fact were dangerous to patients. The other found that some blood pressure drugs did not increase the risk of Covid-19 and might even be protective.

Both studies were led by a professor at Harvard, and both depended on a huge international database of patient medical records that few experts had ever heard of.

But on Thursday, the studies were retracted by the scientific journals in which they had appeared, The New England Journal of Medicine and The Lancet, because the authors could not verify the data on which the results depended.

The retractions may breathe new life into the antimalarial drugs hydroxychloroquine and chloroquine, relentlessly promoted by Mr.

Read More

U.K. Lab to Sidestep Drug Industry to Sell Potential Virus Vaccine

LONDON — A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries.

Scientists, nonprofit groups and public health experts have urged that any successful vaccine to combat the pandemic be distributed at the lowest possible cost and on the basis of need rather than profit. But for-profit drug giants or biotechnology start-ups have dominated the development race, especially in the United States, a vital market because of its high drug prices.

The British laboratory, at Imperial College London, could alter that landscape, in part because its technology has the potential to develop a vaccine that is cheaper and easier to manufacture than others, said Robin Shattock, the lead scientist on the project.

If successful, he said, the vaccine’s lower cost could appeal to the

Read More